FDA PRODUCT CODE · CLASS II

LJS — Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days

What these counts are not

Clearance and recall counts are SPEQ’s aggregation of FDA’s own published records for the code. A recall count is a measure of history, not of a device’s safety, neither number is an FDA rating, and SPEQ is not affiliated with the FDA.

DEVICE CLASS
Class II
REGULATION
21 CFR 880.5970
MEDICAL SPECIALTY
General Hospital
REVIEW PANEL
HO
✓ Implant— Life-sustaining— GMP-exempt— Third-party review eligible
10
510(K)/PMA CLEARANCES
510k: 10
134
RECALL ENTRIES

What this classification requires

Every statement below is FDA’s own classification record for this product code, quoted from the device classification field reference. The SPEQ reading beneath each one is SPEQ’s interpretation of what it means for the work, and is not FDA text.

PREMARKET PATHWAY

510(K)

SPEQ READINGA premarket notification under 21 CFR Part 807 Subpart E is the route for this code. The submission argues substantial equivalence to a legally marketed predicate, so the engineering question is which predicate the design can actually be compared against, and the evidence question is what testing supports that comparison.

DEVICE CLASS

Class II (moderate to high risk): general controls and special controls

SPEQ READINGSpecial controls are the distinguishing feature: performance standards, guidance documents, patient registries or postmarket surveillance named for the device type. Find the special controls before designing the test plan — they usually name the tests.

MALFUNCTION REPORTING

Device is eligible for The Voluntary Malfunction Summary Reporting Program

SPEQ READINGMalfunctions for this code may be reported in periodic summary form rather than as individual MDRs under 21 CFR Part 803. Eligibility is a property of the product code; using it is a decision the manufacturer makes and must be able to justify.

GMP / QUALITY SYSTEM

Not exempt due to Good Manufacturing Practice (GMP)/Quality System

SPEQ READINGThe full Quality Management System Regulation (21 CFR 820, incorporating ISO 13485:2016) applies, and is what an FDA inspection of this device will be conducted against.

IMPLANT

Device is implantable

SPEQ READINGImplant status raises the evidentiary bar on biocompatibility and on traceability from finished device back to material lot.

LIFE-SUSTAINING

Device is not used for life sustaining purposes

SPEQ READINGNo life-sustaining designation attaches to this code.

THIRD-PARTY REVIEW

Device is not a candidate for a third party review program

SPEQ READINGFDA reviews any premarket notification for this code directly.

Other product codes under 21 CFR 880.5970

One regulation usually governs several product codes. These share this code’s regulation, and therefore its classification basis.

21 CFR 880.5970 — Percutaneous, implanted, long-term intravascular catheter

The classification regulation for this product code, as published by the Office of the Federal Register. This is the regulation text itself — no SPEQ interpretation appears in it.

(a) Identification. A percutaneous, implanted, long-term intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings, such as luer hubs, and accessories that facilitate the placement of the device. The device allows for repeated access to the vascular system for long-term use of 30 days or more, and it is intended for administration of fluids, medications, and nutrients; the sampling of blood; and monitoring blood pressure and temperature. The device may be constructed of metal, rubber, plastic, composite materials, or any combination of these materials and may be of single or multiple lumen design.

(b) Classification. Class II (special controls) Guidance Document: “Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters.” [65 FR 37043, June 13, 2000]

Source: Electronic Code of Federal Regulations, Title 21. 21 CFR is a work of the United States Government and is in the public domain. SPEQ read this section on October 22, 2026. CFR is amended continuously, so verify against the source before acting on it: read 21 CFR 880.5970 on eCFR →

Recent clearances

K260080Medical Components, Inc. · 510k2026-10-09
K260929Navi Medical Technologies · 510k2026-04-17
K252373Spectrum Vascular · 510k2025-12-16
K252792Piccolo Medical, Inc. · 510k2025-11-17
K243458Access Vascular, Inc. · 510k2025-08-01
K251212Access Vascular, Inc. · 510k2025-07-01
K243484Piccolo Medical, Inc. · 510k2025-05-29
K241587Vygon Corporation · 510k2025-02-26

Recent recalls

Access Vascular, IncOpen, Classified · 2023-10-13

Specific lots of the Dual Lumen HydroPICC Kits were provided with the incorrect revision of the Instructions For Use (IFU) which do not include the following warnings statement: HydroPICC Dual Lumen Catheter is for adult use only. There is a potential risk to health should the HydroPICC Dual Lumen C

Access Vascular, IncOpen, Classified · 2023-10-13

Specific lots of the Dual Lumen HydroPICC Kits were provided with the incorrect revision of the Instructions For Use (IFU) which do not include the following warnings statement: HydroPICC Dual Lumen Catheter is for adult use only. There is a potential risk to health should the HydroPICC Dual Lumen C

ARROW INTERNATIONAL Inc.Open, Classified · 2023-10-05

This recall has been initiated due to reports that the product code and product name were incorrectly listed on the lidstock of affected kits.

ARROW INTERNATIONAL Inc.Open, Classified · 2023-10-05

This recall has been initiated due to reports that the product code and product name were incorrectly listed on the lidstock of affected kits.

Bard Peripheral Vascular IncOpen, Classified · 2023-02-01

Due to the adhesive provided within the catheter repair kits maybe hardened/coagulated (unusable).

Access Vascular, Inc.Terminated · 2022-11-08

Scalpel and StatLock components packaged with specific lots of the HydroPICC catheter have a shorter expiration date than what is listed on the outer kit package.

Bard Access Systems Inc.Terminated · 2018-02-06

Possible leaks on the 3 Fr. Single lumen and 4 Fr. Dual lumen PowerPICC catheters at the luer hub extension leg junction.

Arrow International IncTerminated · 2015-11-04

Possibility that the catheter peel-away component hub tabs may prematurely detach when the practitioner begins to peel apart the sheath body from the catheter. Although the issue does not pose a significant risk to the patient, it may cause a delay of treatment when placing the catheter.

Source: FDA device classification, 510(k)/PMA, and recall datasets. Recall entries count distinct FDA recall numbers, so one recall event affecting several products appears as several entries. Browse every product code SPEQ tracks →